62
Views
1
CrossRef citations to date
0
Altmetric
Articles

Anthropometric Evaluation and Functional Assessment of Patients with Pulmonary Hypertension and its Relationship with Pulmonary Circulation Parameters and Functional Performance

, MD, , RD & , PhD
Pages 423-428 | Received 24 Sep 2017, Accepted 12 Dec 2017, Published online: 13 Mar 2018

References

  • McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573–619. doi:10.1016/j.jacc.2009.01.004. PMID: 19389575.
  • Galiè N, Humbert M, Vachiery JL, Gibbs JS, Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf AV, Ghofrani MBA, Sanchez MAG, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir. 2015;46:903–75. doi:10.1183/13993003.01032-2015.
  • Tapson VF, Platt DM, Xia F, Teal SA, de la Orden M, Divers CH, Satler CA, Joish VN, Channick RN. Monitoring for pulmonary hypertension following pulmonary embolism: The INFORM Study. Am J Med. 2016;129:978–85. doi:10.1016/j.amjmed.2016.03.006. PMID: 27046247.
  • Galiè N, Rubin LJ, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet. 2008;371:2093–100. doi:10.1016/S0140-6736(08)60919-8. PMID: 18572079.
  • Ghofrani HA, Distler O, Gerhardt F, Gorenflo M, Grünig E, Haefeli WE, Held M, Hoeper MM, Kähler CM, Kaemmerer H, Klose H, Köllner V, Kopp B, Mebus S, Meyer A, Miera O, Pittrow D, Riemekasten G, Rosenkranz S, Schranz D, Voswinckel R, Olschewski H. Treatment of pulmonary arterial hypertension (PAH): updated recommendations of the Cologne Consensus Conference. Int J Cardiol. 2011;154:S20–33. doi:10.1016/S0167-5273(11)70490-9. PMID: 22221970.
  • Galiè N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62:D60–72. doi:10.1016/j.jacc.2013.10.031. PMID: 24355643.
  • Gall H, Sommer N, Milger K, Richter MJ, Voswinckel R, Bandorski D, Seeger W, Grimminger F, Ghofran HA. Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study. BMC Pulm Med. 2016;16:1–9. doi:10.1186/s12890-015-0164-2. PMID: 26728359.
  • Lipshultz SE, Miller TL, Wilkinson JD, Scott GB, Somarriba G, Cochran TR, Fisher SD. Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America. J Int AIDS Soc. 2013;16:1–19. doi:10.7448/IAS.16.1.18597. PMID: 24008177.
  • Genctoy G, Arikan S, Eldem O. Pulmonary hypertension associates with malnutrition and body composition hemodialysis patients. Ren Fail. 2015;37:273–79. doi:10.3109/0886022X.2014.986705. PMID: 25410114.
  • Burger CD, Foreman AJ, Miller DP, Safford RE, McGoon MD, Badesch DB. Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey. Mayo Clin Proc. 2011;86:105–12. doi:10.4065/mcp.2010.0394. PMID: 21282484.
  • Lourenço AP, Vasques-Nóvoa F, Fontoura D, Brás-Silva C, Roncon-Albuquerque R Jr, Leite-Moreira AF. A Western-type diet attenuates pulmonary hypertension with heart failure and cardiac cachexia in rats. J Nutr. 2011;141:1954–60. doi:10.3945/jn.111.145763. PMID: 21940516.
  • Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:34–41. doi:10.1016/j.jacc.2013.10.029.
  • World Health Organization (WHO) consultation on obesity. Obesity: Preventing and managing the global epidemic. Geneva (Switzerland): World Health Organization; 1997. Technical Report Series no.: 894.
  • Lameu EB, Gerude MF, Corrêa RC, Lima KA. Adductor policis muscle: a new anthropometric parameter. Rev Hosp Clin Fac Med Sao Paulo 2004;59(2):57–62. doi:10.1590/S0041-87812004000200002.
  • Detsky AS, Mclaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assessment of nutritional status? J Parenter Enteral Nutr. 1987;11:8–13. doi:10.1177/014860718701100108. PMID: 3820522.
  • Lohman TG. Advances in body composition assessment: current issues in exercise science. Monograph 3. Champaign (IL): Human Kinetics; 1992.
  • Franssen FM, Rutten EP, Groenen MT, Vanfleteren LE, Wouters EF, Spruit MA. New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank. J Am Med Dir Assoc. 2014;15:448. doi:10.1016/j.jamda.2014.03.012. PMID: 24755478.
  • Schvartzman PR, Fuchs FD, Mello AG, Coli M, Schvartzman M, Moreira LB. Normal values of echocardiographic measurements: a population-based study. Arq Bras Cardiol. 2000;75:107–14. doi:10.1590/S0066-782X2000000800003. PMID: 10983027.
  • McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation. 2001;104:2797–802. doi:10.1161/hc4801.100076. PMID: 11733397.
  • American Thoracic Society. ATS statement. guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–17. doi:10.1164/ajrccm.166.1.at1102. PMID: 12091180.
  • European Society of Cardiology. Guidelines for the diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J. 2009;30:2493–537. PMID: 19713419.
  • Sitbon O, Humbert M, Nunes H, Paren F, Garcia G, Hervè P, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 2002;40:780–88. doi:10.1016/S0735-1097(02)02012-0. PMID: 12204511.
  • Borg G. Escalas de Borg para a dor e o esforço percebido. São Paulo (Brazil): Manole; 2000.
  • Neder AJ, Nery L. Fisiologia clínica do exercício teoria e prática. São Paulo (Brazil): Artes Médicas; 2003.
  • Malachias MVB, Souza WKSB, Plavnik FL, Rodrigues CIS, Brandão AA, Neves MFT, Bortolotto LA, Franco RJS, Poli-de-Figueiredo CE, Jardim PCBV, Amodeo C, Barbosa ECD, Koch V, Gomes MAM, Paula RB, Póvoa RMS, Colombo FC, Ferreira Filho S, Miranda RD, Machado CA, Nobre F, Nogueira AR, Mion Júnior D, Kaiser S, Forjaz CLM, Almeida FA, Martim JFV, Sass N, Drager LF, Muxfeldt E, Bodanese LC, Feitosa AD, Malta D, Fuchs S, Magalhães ME, Oigman W, Moreira Filho O, Pierin AMG, Feitosa GS, Bortolotto MRFL, Magalhães LBNC, Silva ACS, Ribeiro JM, Borelli FAO, Gus M, Passarelli Júnior O, Toledo JY, Salles GF, Martins LC, Jardim TSV, Guimarães ICB, Antonello IC, Lima Júnior E, Matsudo V, Silva GV, Costa LS, Alessi A, Scala LCN, Coelho EB, Souza D, Lopes HF, Gowdak MMG, Cordeiro Júnior AC, Torloni MR, Klein MRST, Nogueira PK, Lotaif LAD, Rosito GBA, Moreno Júnior H. 7ª Diretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol. 2016;107:1–83. PMID: 27819380.
  • Prídavková D, Kantárová D, Lišková R, Červeň P, Kovář F, Mokáň M. The role of epicardial fat and obesity parameters in the prediction of coronary heart disease. Vnitr Lek. 2016;62:256–62. PMID: 27250602.
  • Schols AM. Nutritional advances in patients with respiratory diseases. Eur Respir Rev. 2015;24:17–22. doi:10.1183/09059180.00010914. PMID: 25726550.
  • Baffi CW, Wood L, Winnica D, Strollo PJ Jr, Gladwin MT, Que LG, Holguin F. Metabolic Syndrome and the Lung. Chest. 2016;149:1525–34. doi:10.1016/j.chest.2015.12.034. PMID: 26836925.
  • Brittain EL, Nwabuo C, Xu M, Gupta DK, Hemnes AR, Moreira HT, Vasconcellos HD, Terry JG, Carr JJ, Lima JAC. Echocardiographic pulmonary artery systolic pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations with race and metabolic dysregulation. J Am Heart Assoc. 2017;30:6.
  • Zamanian RT, Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, Rabinovitch M, Doyle RL. Insulin resistance in pulmonary arterial hypertension. European respiratory journal. 2009;33:318–324. doi:10.1183/09031936.00000508. PMID: 19047320.
  • Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax. 2010;65:113–17. doi:10.1136/thx.2009.117168. PMID: 19720606.
  • Kawamoto A, Kato T, Minamino-Muta E, Okano Y, Shioi T, Kimura T. Relationships between nutritional status and markers of congestion in patients with pulmonary arterial hypertension. Int J Cardiol. 2015;187:27–28. doi:10.1016/j.ijcard.2015.03.354. PMID: 25828304.
  • Hu EC, He JG, Liu ZH, Ni XH, Zheng YG, Gu Q, Zhao ZH, Xiong CM. Survival advantages of excess body mass index in patients with idiopathic pulmonary arterial hypertension. Acta Cardiol. 2014;69:673–78. doi:10.1080/AC.69.6.1000010. PMID: 25643438.
  • Marini C, Formichi B, Bauleo C, Michelassi C, Airò E, Rossi G, Giuntini C. Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension. Intern Emerg Med. 2016;11:941–52. doi:10.1007/s11739-016-1446-2. PMID: 27052360.
  • McGoon MD. The assessment of pulmonary hypertension. Clin Chest Med. 2001;22:493–508. doi:10.1016/S0272-5231(05)70286-0. PMID: 11590843.
  • Singer J, Yelin EH, Katz PP, Sanchez G, Iribarren C, Eisner MD, Blanc PD. Respiratory and skeletal muscle strength in COPD: Impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev. 2011;31:111–19. doi:10.1097/HCR.0b013e3182033663. PMID: 21240003.
  • Calik-Kutukcu E, Savci S, Saglam M, Vardar-Yagli N, Inal-Ince D, Arikan H, Aribas Z, Ozer O, Bosnak-Guclu M, Coplu L. A comparison of muscle strength and endurance, exercise capacity, fatigue perception and quality of life in patients with chronic obstructive pulmonary disease and healthy subjects: a cross-sectional study. BMC Pulm Med. 2014;14:6. doi:10.1186/1471-2466-14-6. PMID: 24468029.
  • Matura LA, Shou H, Fritz JS, Smith KA, Vaidya A, Pinder D, Archer-Chicko C, Dubow D, Palevsky HI, Sommers MS, Kawut SM. Physical activity and symptoms in pulmonary arterial hypertension. Chest. 2016;150:46–56. doi:10.1016/j.chest.2016.02.633. PMID: 26892602.
  • Annemie MWJ, Schols AM. Nutrition as a metabolic modulator in COPD. Chest. 2013;144:1340–45. doi:10.1378/chest.13-0326. PMID: 24081345.
  • Van den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, Barreiro E, Schols AM, Gosker HR. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol. 2013;114:1319–28. doi:10.1152/japplphysiol.00508.2012. PMID: 22815389.
  • Layec G, Haseler LJ, Hoff J, Richardson RS. Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings. Am J Physiol. 2011;300:1142–47.
  • Kim V, Kretschman DM, Sternberg AL, DeCamp MM Jr, Criner GJ. Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency. Am J Respir Crit Care Med. 2012;186:1109–16. doi:10.1164/rccm.201203-0538OC. PMID: 22878279.
  • Franssen FM, O'Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63:1110–17. doi:10.1136/thx.2007.086827.
  • Meek P, Tesfaigzi Y. Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med. 2014;189:274–81. doi:10.1164/rccm.201306-1060OC. PMID: 24274793.
  • Zafrir B, Adir Y, Shehadeh W, Shteinberg M, Salman N, Amir O. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox.” Respir Med. 2013;107:139–46. doi:10.1016/j.rmed.2012.10.019. PMID: 23199841.
  • Galesanu RG, Bernard S, Marquis K, Lacasse Y, Poirier P, Bourbeau J, Maltais F. Obesity in chronic obstructive pulmonary disease: is fatter really better? Can Respir J. 2014;21:297–301. doi:10.1155/2014/181074. PMID: 24791257.
  • Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD. 2015;12:14–18. doi:10.3109/15412555.2014.915934. PMID: 24945083.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.